Premature ovarian failure from current perspective

Gynecological Endocrinology

Volumn 26, Issue 8, 2010, Pages 555-562

  Kokcu, Arif ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Amenorrhoea; infertility; ovary

Indexed keywords

ESTROGEN;

AMENORRHEA; AUTOIMMUNITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; COUNSELING; EARLY MENOPAUSE; ENVIRONMENTAL FACTOR; FRAGILE X SYNDROME; GALACTOSEMIA; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC SCREENING; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPISM; IATROGENIC DISEASE; OVARY FOLLICLE ATRESIA; OVARY FUNCTION; OVULATION INDUCTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW; ULTRASOUND; FEMALE; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS;

FEMALE; HUMANS; OVARIAN FAILURE, PREMATURE; PROGNOSIS; PRIMARY OVARIAN INSUFFICIENCY;

EID: 77954801625     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.488773     Document Type: Review

References (70)

1. Méduri G, Massin N, Guibourdenche J, Bachelot A, Fiori O, Kuttenn F, Misrahi M, Touraine P. Serum anti-mullerian hormone expression in women with POF. Hum Reprod 2007;22:117-123.
2. Rebar RW. Premature ovarian "failure" in the adolescent. Ann N Y Acad Sci 2008;1135:138-145.
3. -Beck-Peccoz P, Persani L. POF. Orphanet J Rare Dis. 2006;1:9.
4. Bretherick KL, Hanna CW, Currie LM, Fluker MR, Hammond GL, Robinson WP. Estrogen receptor a gene polymorphisms are associated with idiopathic POF. Fertil Steril 2008;89:318-324.
5. Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinol Metab Clin North Am 1998;27:989-1006.
6. Nippita TA, Baber RJ. Premature ovarian failure: a review. Climacteric 2007;10:11-22.
7. Tibiletti MG, Testa G, Vegetti W, Alagna F, Taborelli M, Dalprà L, et al. The idiopathic forms of premature menopause and early menopause show the same genetic pattern. Hum Reprod 1999;14:2731-2734.
8. Vegetti W, Marozzi A, Manfredini E, Testa G, Alagna F, Nicolosi A, et al. Premature ovarian failure. Mol Cell Endocrinol 2000;161:53-57.
9. Goswami D, Conway GS. POF. Horm Res 2007;68:196-202.
10. Panay N, Fenton A. Premature ovarian failure: a growing concern. Climacteric 2008;11:1-3.
11. Woad KJ, Watkins WJ, Prendergast D, Shelling AN. The genetic basis of POF. Aust N Z J Obstet Gynaecol 2006;46:242-244.
12. Massin N, Czernichow C, Thibaud E, Kuttenn F, Polak M, Touraine P. Idiopathic POF in 63 young women. Horm Res 2006;65:89-95.
13. Kalu E, Panay N. Spontaneous POF: management challenges. Gynecol Endocrinol 2008;24:273-279.
14. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril 2009;91:1707-1711.
15. Mamas L, Mamas E. POF and dehydroepiandrosterone. Fertil Steril 2009;91:644-646.
16. Cameron M, Grover S, Moore P, Jayasinghe Y. Non-chromosomal, non-iatrogenic POF in an adolescent population: a case series. J Pediatr Adolesc Gynecol 2008;21:3-8.
17. Sinha P, Kuruba N. Premature ovarian failure. J Obstet Gynaecol 2007;27:16-19.
18. Meskhi A, Seif MW. Premature ovarian failure. Curr Opin Obstet Gynecol 2006;18:418-426.
19. Chang SH, Kim CS, Lee KS, Kim H, Yim SV, Lim YJ, et al. Premenopausal factors influencing POF and early menopause. Maturitas 2007;58:19-30.
20. Welt CK. Primary ovarian insufficiency: a more accurate term for POF. Clin Endocrinol (Oxf) 2008;68:499-509.
21. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P. Pathophysiology of impaired ovarian function in galactosaemia. Hum Reprod Update 2006;12:573-584.
22. Schillings WJ, McClamrock HD. Amenorrhea. In: Berek JS, editor. Berek & Novak's gynecology. 14th ed, Philadelphia: Lippincott Williams & Wilkins; 2007. pp 1038-1068.
23. Kalantaridou SN, Nelson LM. POF is not premature menopause. Ann N Y Acad Sci 2000;900:393-402.
24. Cohen DP. Amenorrhea. In: Gibbs RS, Karlan BY, Haney AF, Nygaard IE, editors. Danforth's obstetrics and gynecology. 10th ed, Philadelphia: Lippincott Williams & Wilkins; 2008. pp 648-663.
25. Gleicher N, Barad D,Weghofer A. Functional autoantibodies, a newparadigm in autoimmunity?AutoimmunRev 2007; 7:42-45.
26. Hui ES, Udofa EA, Soto J, Vanderhoof VH, Zachman K, Tong ZB, et al. Investigation of the human stem cell factor KIT ligand gene, KITLG, in women with 46,XX spontaneous POF. Fertil Steril 2006;85:1502-1507.
27. Shiina H, Matsumoto T, Sato T, Igarashi K, Miyamoto J, Takemasa S, et al. POF in androgen receptor-deficient mice. Proc Natl Acad Sci U S A 2006;103:224-229.
28. Sugawa F, Wada Y, Maruyama T, Uchida H, Ishizuka B, Ogata T. POF and androgen receptor gene CAG repeat lengths weighted by X chromosome inactivation patterns. Fertil Steril 2009;91:649-652.
29. Chatterjee S, Singh R, Kadam S, Maitra A, Thangaraj K, Meherji P, et al. Longer CAG repeat length in the androgen receptor gene is associated with POF. Hum Reprod 2009;24:3230-3235.
30. Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S, et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous POF. Fertil Steril 2005;84:958-965.
31. Chand AL, Harrison CA, Shelling AN. Inhibin and premature ovarian failure. Hum Reprod Update 2010;16:39-50.
32. Meczekalski B. Oocyte-specific genes: role in fertility and infertility. J Endocrinol Invest 2009;32:474-481.
33. Toniolo D. X-linked POF: a complex disease. Curr Opin Genet Dev 2006;16:293-300.
34. Martin JR, Arici A. Fragile X and reproduction. Curr Opin Obstet Gynecol 2008;20:216-220.
35. Hunter JE, Epstein MP, Tinker SW, Charen KH, Sherman SL. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genet Epidemiol 2008;32:553-559.
36. Corrigan EC, Raygada MJ, Vanderhoof VH, Nelson LM. A woman with spontaneous POF gives birth to a child with fragile X syndrome. Fertil Steril 2005;84:1508.
37. Mlinar B, Gersak K, Karas N, Zitnik IP, Battelino T, Lukac-Bajalo J. Galactose-1-phosphate uridyl transferase gene mutations in women with POF. Fertil Steril 2005;84:253-255.
38. Hoek A, Schoemaker J, Drexhage HA. POF and ovarian autoimmunity. Endocr Rev 1997;18:107-134.
39. Kelkar RL, Meherji PK, Kadam SS, Gupta SK, Nandedkar TD. Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with POF. J Reprod Immunol 2005;66:53-67.
40. Sundblad V, Bussmann L, Chiauzzi VA, Pancholi V, Charreau EH. Alpha-enolase: a novel autoantigen in patients with POF. Clin Endocrinol (Oxf) 2006;65:745-751.
41. Tuohy VK, Altuntas CZ. Autoimmunity and POF. Curr Opin Obstet Gynecol 2007;19:366-369.
42. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996;81:1871-1876.
43. Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009;161:11-20.
44. Busacca M, Riparini J, Somigliana E, Oggioni G, Izzo S, Vignali M, et al. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol 2006;195:421-425.
45. Schover LR. POF and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008;26: 753-758.
46. Imai A, Furui T. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues. J Obstet Gynaecol 2007;27:20-24.
47. Brunner HI, Bishnoi A, Barron AC, Houk LJ, Ware A, Farhey Y, et al. Disease outcomes and ovarian function of childhood- onset systemic lupus erythematosus. Lupus 2006;15: 198-206.
48. Gallicchio L, Miller S, Greene T, Zacur H, Flaws JA. POF among hairdressers. Hum Reprod 2009;24:2636-2641.
49. Panay N, Kalu E. Management of premature ovarian failure. Best Pract & Res Clin Obstet Gynaecol 2009;23: 129-140.
50. Massin N, Méduri G, Bachelot A, Misrahi M, Kuttenn F, Touraine P. Evaluation of different markers of the ovarian reserve in patients presenting with POF. Mol Cell Endocrinol 2008;282:95-100.
51. Twigg S, Wallman L, McElduff A. The resistant ovary syndrome in a patient with galactosemia: a clue to the natural history of ovarian failure. J Clin Endocrinol Metab 1996;81: 1329-1331.
52. Massin N, Gougeon A, Meduri G, Thibaud E, Laborde K, Matuchansky C, et al. Significance of ovarian histology in the management of patients presenting a POF. Hum Reprod 2004;19:2555-2560.
53. Bidet M, Bachelot A, Touraine P. Premature ovarian failure: predictability of intermittent ovarian function and response to ovulation induction agents. Curr Opin Obstet Gynecol 2008; 20:416-420.
54. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005;11:391-410.
55. van Beek RD, van den Heuvel-Eibrink MM, Laven JS, de Jong FH, Themmen AP, Hakvoort-Cammel FG, et al. Antimullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 2007;92:3869-3874.
56. Tsigkou A, Marzotti S, Borges L, Brozzetti A, Reis F, Candeloro P, et al. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J Clin Endocrinol Metab 2008; 93:1263-1269.
57. Nilsson E, Rogers N, Skinner MK. Actions of anti-mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction 2007;134:209-221.
58. Bukovsky A, Caudle MR. Immune physiology of the mammalian ovary - a review. Am J Reprod Immunol 2008; 59:12-26.
59. de Taraciuk MB, Nolting M, Fernandez G, Colela D, Onetto C, Straminsky V. Psychological assessment of patients with POF. Gynecol Endocrinol 2008;24:44-53.
60. Kalantaridou SN, Naka KK, Bechlioulis A, Makrigiannakis A, Michalis L, Chrousos GP. POF, endothelial dysfunction and estrogen-progestogen replacement. Trends Endocrinol Metab 2006;17:101-109.
61. Uygur D, Sengül O, Bayar D, ErdinçS, Batioglu S, Mollamahmutoglu L. Bone loss in young women with POF. Arch Gynecol Obstet 2005;273:17-19.
62. Kalantaridou SN, Calis KA, Vanderhoof VH, Bakalov VK, Corrigan EC, Troendle JF, et al. Testosterone deficiency in young women with 46,XX spontaneous POF. Fertil Steril 2006;86:1475-1482.
63. Kalantaridou SN, Calis KA. Testosterone therapy in premenopausal women. Semin Reprod Med 2006;24:106-114.
64. Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with POF: a randomized, placebo-controlled trial. Fertil Steril 2007;87: 858-861.
65. Blumenfeld Z. Pregnancies in patients with POF gonadotropin stimulation and pretreatment with ethinyl estradiol. Fertil Steril 2007;88:763.
66. Badawy A, Goda H, Ragab A. Induction of ovulation in idiopathic POF: a randomized double-blind trial. Reprod Biomed Online 2007;15:215-219.
67. Oktay K, Oktem O. Regeneration of oocytes after chemotherapy: connecting the evidence from mouse to human. J Clin Oncol 2007;25:3185-3187.
68. Vandborg M, Lauszus FF. POF and pregnancy. Arch Gynecol Obstet 2006;273:387-388.
69. Dolmans MM, Donnez J, Camboni A, Demylle D, Amorim C, Van Langendonckt A, IVF outcome in patients with orthotopically transplanted ovarian tissue. Hum Reprod 2009;24:2778-2787.
70. Silber SJ. Fresh ovarian tissue and whole ovary transplantation. Semin Reprod Med 2009;27:479-485.